News Details

FDA Issues Safety Alert to Stop Using Empowered Diagnostics COVID-19 Tests

The United States Food and Drug Administration (FDA) has issued a safety alert warning people to stop using the Empowered Diagnostics CovClear COVID-19 Rapid Antigen Test and ImmunoPass COVID-19 Neutralizing Antibody Rapid Test.  FDA notes that neither test has been authorized, cleared, or approved by the FDA for distribution or use in the United States.  FDA also notes that it is concerned about the potentially higher risk of false results when using these unauthorized tests.  To read the FDA safety alert on the Empowered Diagnostics COVID-19 tests, use the link below.